These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8069546)

  • 1. Simulation and optimisation of a self-regulating insulin delivery system.
    Fischel-Ghodsian F; Newton JM
    J Drug Target; 1993; 1(1):67-80. PubMed ID: 8069546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggered release of insulin from glucose-sensitive enzyme multilayer shells.
    Qi W; Yan X; Fei J; Wang A; Cui Y; Li J
    Biomaterials; 2009 May; 30(14):2799-806. PubMed ID: 19203789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A.
    Liu F; Song SC; Mix D; Baudys M; Kim SW
    Bioconjug Chem; 1997; 8(5):664-72. PubMed ID: 9327129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
    Nam K; Watanabe J; Ishihara K
    Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural network modeling and control of type 1 diabetes mellitus.
    El-Jabali AK
    Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, characterization and evaluation of an auto-regulatory delivery system for insulin.
    Vyas SP; Karajgi JS; Gogoi PJ; Jain NK
    J Microencapsul; 1991; 8(2):235-42. PubMed ID: 1765903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatically controlled drug delivery.
    Fischel-Ghodsian F; Brown L; Mathiowitz E; Brandenburg D; Langer R
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2403-6. PubMed ID: 3281165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-sensitive membranes containing glucose oxidase: activity, swelling, and permeability studies.
    Kost J; Horbett TA; Ratner BD; Singh M
    J Biomed Mater Res; 1985; 19(9):1117-33. PubMed ID: 3910652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption.
    Fan YF; Wang YN; Fan YG; Ma JB
    Int J Pharm; 2006 Nov; 324(2):158-67. PubMed ID: 16814967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based blood glucose control for Type 1 diabetes via parametric programming.
    Dua P; Doyle FJ; Pistikopoulos EN
    IEEE Trans Biomed Eng; 2006 Aug; 53(8):1478-91. PubMed ID: 16916082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
    Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature and pH-responsive polymeric composite membranes for controlled delivery of proteins and peptides.
    Zhang K; Wu XY
    Biomaterials; 2004 Oct; 25(22):5281-91. PubMed ID: 15110479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing an enzymatic oscillator: bistability and feedback controlled oscillations with glucose oxidase in a continuous flow stirred tank reactor.
    Vanag VK; Míguez DG; Epstein IR
    J Chem Phys; 2006 Nov; 125(19):194515. PubMed ID: 17129131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal H infinity insulin injection control for blood glucose regulation in diabetic patients.
    Chee F; Savkin AV; Fernando TL; Nahavandi S
    IEEE Trans Biomed Eng; 2005 Oct; 52(10):1625-31. PubMed ID: 16235648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.